Mikhail Batin posts

Материал из hpluswiki
Версия от 12:00, 13 июня 2024; Rodion (обсуждение | вклад) (Новая страница: «Here are some of the most interesting posts of [http://facebook.com/mikhail.batin Mikhail Batin], with a brief description. <br/> You can always translate them via [https://translate.google.com/?sl=ru&tl=en&op=websites google website translation]<br/> Currently only posts from livejournal for period 04.2009 - 01.2010 are available.<br/> === Promoting the ideas of scientific immortalism === * [https://m-batin.livejournal.com/910.html Problems of implementing...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигации Перейти к поиску

Here are some of the most interesting posts of Mikhail Batin, with a brief description.
You can always translate them via google website translation
Currently only posts from livejournal for period 04.2009 - 01.2010 are available.

Promoting the ideas of scientific immortalism

Also:

Approaches to aging research

Also:

Investing in aging research

  • Industry Review on Aging - 2, 38 issues that would be good to cover in such a review (August 2019). Some interesting snippets from comments: "I know that Sergei Brin (the founder of Google) has a wife who is a microbiologist, and he himself seems to be interested in the subject. Bill Gates has repeatedly declared an interest in biological research in order to defeat disease and prolong life. In general, among computer scientists, such interests are easy to arise. In Russia, Oleg Deripaska sponsors one or two foundations, and Gazprom has sponsored some projects in St. Petersburg. On the whole, there is interest, but the long absence of "stunning" results dulls this interest. Bryntsalov, a drug manufacturer and millionaire, regularly uses stem cells and sponsors relevant research." <...> "The scientist who cloned "Dolly the sheep" seems to be working for a company/fund in Asia (Taiwan, South Korea or others) now on the subject of rejuvenation"
  • 15 Mistakes of a Life Extension Research Investor (October 2009)

Miscellaneous